Lenexa, KS, United States of America

Lisa M Harlan-Williams


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Lisa M Harlan-Williams

Introduction

Lisa M Harlan-Williams is an innovative inventor based in Lenexa, Kansas, who has made significant contributions to the field of medicine. With a focus on breast and ovarian cancer treatments, her work aims to provide new therapeutic options for patients facing these serious health challenges.

Latest Patents

Harlan-Williams holds a patent for her invention titled "BRCA1-based breast or ovarian cancer treatment agents and methods of use." This patent encompasses a pharmaceutical composition designed to treat, inhibit, and prevent breast and/or ovarian cancer. The composition includes molecules with structures of Compounds 1-38, along with a pharmaceutically acceptable carrier. The formulation can be administered through various methods, including oral, systemic, transdermal, intranasal, suppository, parenteral, intramuscular, intravenous, or subcutaneous routes. Importantly, the compounds are present in therapeutically effective amounts, aimed at not just treating cancer but enhancing the production of BRCA1.

Career Highlights

Harlan-Williams is affiliated with the University of Kansas, where she engages in research that contributes to the development of innovative cancer treatments. Her dedication to advancing medical science has positioned her as a notable figure in her field.

Collaborations

Throughout her career, Harlan-Williams has collaborated with prominent colleagues such as Roy A Jensen and Frank John Schoenen. These partnerships reflect her commitment to teamwork and the advancement of research in the biomedical arena.

Conclusion

Lisa M Harlan-Williams exemplifies the spirit of innovation in the field of cancer treatment. Her patent highlights her contributions to medical science and demonstrates her dedication to improving the lives of cancer patients. Through her work at the University of Kansas and collaborations with esteemed colleagues, she continues to drive progress in this critical area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…